Subventricular Zone Progenitors
Introduction
flowchart TD
Subventricular_Zone_Progenitor["Subventricular Zone Progenitors"]
Subventricular_Zone_Progenitor["Introduction"]
Subventricular_Zone_Progenitor -->|"related to"| Subventricular_Zone_Progenitor
style Subventricular_Zone_Progenitor fill:#81c784,stroke:#333,color:#000
Subventricular_Zone_Progenitor["table"]
Subventricular_Zone_Progenitor -->|"related to"| Subventricular_Zone_Progenitor
style Subventricular_Zone_Progenitor fill:#81c784,stroke:#333,color:#000
Subventricular_Zone_Progenitor["class"]
Subventricular_Zone_Progenitor -->|"related to"| Subventricular_Zone_Progenitor
style Subventricular_Zone_Progenitor fill:#81c784,stroke:#333,color:#000
style Subventricular_Zone_Progenitor fill:#4fc3f7,stroke:#333,color:#000
...
Subventricular Zone Progenitors
Introduction
Mermaid diagram (expand to render)
<table class="infobox infobox-cell"> <tr> <th class="infobox-header" colspan="2">Subventricular Zone Progenitors</th> </tr> <tr> <td class="label">Marker</td> <td>Cell Type</td> </tr> <tr> <td class="label">[GFAP](/entities/gfap) </td> <td>Type B</td> </tr> <tr> <td class="label">NES </td> <td>Type B</td> </tr> <tr> <td class="label">EGFR </td> <td>Type C</td> </tr> <tr> <td class="label">DLX2 </td> <td>Type C</td> </tr> <tr> <td class="label">DCX </td> <td>Type A</td> </tr> <tr> <td class="label">PSA-NCAM </td> <td>Type A</td> </tr> <tr> <td class="label">Subregion</td> <td>Cell Types</td> </tr> <tr> <td class="label">Dorsal SVZ</td> <td>Type B, C</td> </tr> <tr> <td class="label">Lateral SVZ</td> <td>Type B, C</td> </tr> <tr> <td class="label">Ventral SVZ</td> <td>Type B</td> </tr> </table>
The subventricular zone (SVZ) is the largest neurogenic niche in the adult mammalian brain, containing neural stem cells (NSCs) that continuously generate new [neurons](/entities/neurons) throughout life. Located along the lateral ventricles, SVZ progenitors give rise to olfactory bulb interneurons and, to a lesser extent, other neuronal populations, making this region crucial for brain plasticity and repair.[@lim2016]
Cellular Morphology SVZ contains distinct cell types arranged in a niche architecture:
Type B Cells (Neural Stem Cells)
Soma : Small (8-12 μm), elongated or oval
Processes : Extend toward ventricle and blood vessels
Primary cilia : Contact cerebrospinal fluid
Junctional complexes : E-cadherin connections
Type C Cells (Transit-Amplifying Progenitors)
Soma : Larger (10-15 μm), round
High proliferation : Rapid cell division
Marker expression : Intermediate between B and A cells
Type A Cells (Neuroblasts)
Soma : Small (8-10 μm), elongated
Chain migration : Travel in chains via rostral migratory stream
Axonal proteins : Express [TAU](/proteins/tau), MAP2
Marker Genes
Normal Function
Neurogenesis
Olfactory bulb neurons : ~700-1000 new neurons/day in mice
Interneuron subtypes : GABAergic granule and periglomerular cells
Circuit integration : New neurons form functional synapses
Brain Repair
Stroke response : Increased proliferation after ischemia
Migration to damage : Neuroblasts can redirect to injury sites
Regeneration limits : Limited functional recovery in humans
Niche Regulation
Vascular support : Blood vessel contacts
CSF signaling : Ventricular signaling
Astrocyte support : EGF and BDNF provision
Disease Associations
Alzheimer's Disease SVZ neurogenesis is affected in AD:
Early decline : Reduced proliferation precedes pathology
Amyloid effects : [Aβ](/proteins/amyloid-beta) inhibits neurogenesis
Cognitive correlates : New neuron numbers predict memory
Therapeutic target : Enhancing neurogenesis
Parkinson's Disease SVZ in PD:
Dopaminergic neurogenesis : Limited to no dopaminergic replacement
Olfactory dysfunction : Linked to olfactory loss in PD
Endogenous repair : Attempts to enhance SVZ response
Cell therapy source : SVZ cells as transplant source
Stroke SVZ responds to stroke:
Proliferation surge : 2-10x increase post-stroke
Migration to injury : Neuroblasts redirect to damaged striatum
Differentiation limits : Mainly glial, limited neuronal
Therapeutic potential : Growth factor enhancement
Brain Tumors SVZ cells in tumor biology:
Glioma origin : May be cells of origin for some gliomas
Tumor niche : Support tumor growth
Therapeutic resistance : Treatment-resistant cells
Vulnerability Mechanisms
Reduced proliferation : Decline begins in early adulthood
Cellular senescence : p16INK4a accumulation
Niche deterioration : Decreased vascular support
Inflammatory Vulnerability
Microglial activation : Pro-inflammatory cytokines inhibit
Chronic inflammation : Sustained reduction
Cytokine effects : TNF-α, IL-6 impair neurogenesis
Hypoxia : HIF1α role in niche
Growth factor decline : Reduced EGF, BDNF
Energy stress : AMPK activation inhibits
Region Distribution
Therapeutic Implications
Growth factor delivery : EGF, BDNF, GDNF
Small molecule agonists : Enhance proliferation
Cell transplantation : SVZ-derived NSCs
Anti-inflammatory : Reduce microglial activation
See Also
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/)
[KEGG Pathways](https://www.genome.jp/kegg/pathway.html)
Show full description